DOCSLIB.ORG
  • Sign Up
  • Log In
  • Upload
  • Sign Up
  • Log In
  • Upload
  • Home
  • »  Tags
  • »  Dextrothyroxine

Dextrothyroxine

  • United States Patent (19) 11 Patent Number: 6,066,653 Gregg Et Al

    United States Patent (19) 11 Patent Number: 6,066,653 Gregg Et Al

  • Full Text

    Full Text

  • Partial Agreement in the Social and Public Health Field

    Partial Agreement in the Social and Public Health Field

  • Regulation of Pharmaceutical Prices: Evidence from a Reference Price Reform in Denmark

    Regulation of Pharmaceutical Prices: Evidence from a Reference Price Reform in Denmark

  • Screening for Lipid Disorders in Children and Adolescents: Systematic Evidence Review for the U.S

    Screening for Lipid Disorders in Children and Adolescents: Systematic Evidence Review for the U.S

  • Australian Statistics on Medicines 1997 Commonwealth Department of Health and Family Services

    Australian Statistics on Medicines 1997 Commonwealth Department of Health and Family Services

  • 2 12/ 35 74Al

    2 12/ 35 74Al

  • Fifteen Year Mortality in Coronary Drug Project Patients: Long-Term Benefit with Niacin

    Fifteen Year Mortality in Coronary Drug Project Patients: Long-Term Benefit with Niacin

  • I (Acts Whose Publication Is Obligatory) COMMISSION

    I (Acts Whose Publication Is Obligatory) COMMISSION

  • VA/Dod CLINICAL PRACTICE GUIDELINE for TH MANAGEMENT O DYSLIPIDEMIA for CARDIOVASCULAR RISK REDUCTION Department of Veterans Affairs Department of Defense

    VA/Dod CLINICAL PRACTICE GUIDELINE for TH MANAGEMENT O DYSLIPIDEMIA for CARDIOVASCULAR RISK REDUCTION Department of Veterans Affairs Department of Defense

  • Lipotropics, Other

    Lipotropics, Other

  • STATIN-FIBRATE REPORT: Focus on Safety VHA Pharmacy Benefits Management-Strategic Healthcare Group and the Medical Advisory Panel

    STATIN-FIBRATE REPORT: Focus on Safety VHA Pharmacy Benefits Management-Strategic Healthcare Group and the Medical Advisory Panel

  • United States Patent (19) 11 Patent Number: 4,925,672 Gremm Et Al

    United States Patent (19) 11 Patent Number: 4,925,672 Gremm Et Al

  • Data for Drugs

    Data for Drugs

  • Lipotropics, Other Review 03/03/2009

    Lipotropics, Other Review 03/03/2009

  • Marrakesh Agreement Establishing the World Trade Organization

    Marrakesh Agreement Establishing the World Trade Organization

  • Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs

    Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs

  • Hypolipaemic Drugs and Coronary Heart Disease

    Hypolipaemic Drugs and Coronary Heart Disease

Top View
  • Lipid Screening in Childhood and Adolescence for Detection of Familial Hypercholesterolemia: a Systematic Evidence Review for the U.S
  • Multinational, Multi-Database Cohort Study to Assess Adverse Cardiovascular and Cerebrovascular Outcomes and Mortality in Association with Inhaled NVA237 in Europe
  • NVA237 / Glycopyrronium Bromide Multinational, Multi-Database Cohort
  • Landmark Clinical Trials
  • Customs Tariff - Schedule Xxi - 1
  • HDL and Its Role in Cardiovascular Disease: a Primary Care Perspective
  • Landmark Clinical Trials
  • 4. Agents to Raise HDL-C
  • Regulation of Pharmaceutical Prices: Evidence from a Reference Price Reform in Denmark∗
  • Utility of Biomarkers and Imaging in the Development of Drugs for the Treatment of Coronary Atherosclerosis David D
  • ICD-10-CM TABLE of DRUGS and CHEMICALS 2020
  • Mesh Terms for 2002
  • Regulatory Change in Pharmaceutical Price: Evidence from A
  • WO 2U11/132171 Al
  • Pharmaceutical Appendix to the Tariff Schedule 2
  • Title 16. Crimes and Offenses Chapter 13
  • Wo 2010/005480 A2
  • 'Essays in Regulation of Pharmaceutical Markets'


© 2024 Docslib.org    Feedback